- $167.80bn
- $219.60bn
- $62.58bn
Pfizer CEO Bourla plans to attend White House state dinner for China's Xi, source says
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
US weighs allowing most pharma licensing deals with China, sources say
All 50 states sign up for Trump's Medicaid most-favored-nation plan (updated)
Brief: Health Canada Authorizes Pfizer And Biontech's Omicron XFG-Adapted Covid-19 Vaccine
Factbox: Pharma sector doubles down on AI to slash costs, timelines
AstraZeneca's breast cancer pill fails in late-stage trial (updated)
Astrazeneca's breast cancer drug fails late-stage trial
Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers
Novartis India hits record high on retina drugs distribution deal, Pfizer brand acquisition
Brief: Novartis India To Acquire 'Minipress' Trademarks From Pfizer
Medicus Pharma surges on Pfizer licensing deal for experimental cancer therapy
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Trump administration announces drug pricing deals with CSL, Astellas and others (updated)
Trump administration to announce drug pricing deals
Roivant, Priovant launch newly approved rare disease drug Lisraya at $35,000 a month (updated)